Makoto Ota
Founder chez WELBE, INC.
Fortune : 39 M $ au 31/03/2024
Profil
Makoto Ota is the founder of Welbe, Inc. where he holds the title of President & Representative Director since 2011.
He is currently a Director at Welbe Healthcare, Inc. since 2021.
Mr. Ota was also a Director at tella, Inc. in the past.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
WELBE,INC.
20,00% | 27/03/2024 | 5 512 154 ( 20,00% ) | 39 M $ | 31/03/2024 |
Postes actifs de Makoto Ota
| Sociétés | Poste | Début |
|---|---|---|
| WELBE, INC. | Founder | 01/12/2011 |
| Welbe Healthcare, Inc. | Director/Board Member | 01/06/2021 |
Anciens postes connus de Makoto Ota
| Sociétés | Poste | Fin |
|---|---|---|
| TELLA, INC. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
| Welbe, Inc. | |
| Welbe Healthcare, Inc. | Health Services |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
